Gurevičienė, G. (2019). PD-L1 INHIBITOR PEMBROLIZUMAB – FOR FIRST LINE ADVANCED NON-SMALL CELL LUNG CANCER THERAPY. Pulmonology and Allergology, 3(2), 177-182. https://doi.org/10.37499/PIA.136